VistaGen Therapeutics Inc (VTGN)
Healthcare
Biotechnology
0.24 $
+0.0%
vs. previous close
Closing price · As of: 31. Jul 2026
VistaGen Therapeutics Inc (VTGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Operating Cash Flow" came in at -66 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.8 | -4.8 | -7.3 | -9.1 | -15 | -16 | -12 | -45 | -50 | -26 | -42 | -66 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.7 | 0.5 | 0.6 | 0.6 | 0.7 | |
| 2.5 | 4.0 | 0.9 | 2.3 | 3.4 | 3.8 | 2.3 | 3.5 | 3.3 | 2.2 | 4.3 | 4.0 | |
| 2.5 | 42 | 3.6 | 4.4 | 3.6 | 3.8 | 2.3 | 3.5 | – | – | – | – | |
| 2.1 | -0.5 | -0.7 | 0.7 | 1.7 | 0.2 | 3.4 | -1.9 | 2.0 | 0.8 | 4.8 | -0.9 | |
| 0.0 | 0.0 | 0.2 | 0.0 | 0.2 | 0.3 | 0.3 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | |
| 0.0 | 0.0 | -0.2 | 0.0 | -0.2 | -0.3 | -0.3 | -0.2 | -0.7 | -0.1 | -13 | -0.9 | |
| 0.0 | 0.0 | 1,257 | 1,030 | 1,140 | 1,264 | 1,386 | 945 | 867 | – | – | – | |
| 3.1 | 5.3 | 1,257 | 205 | 1,140 | 1,264 | 1,386 | 945 | -0.2 | – | – | – | |
| -0.3 | -0.1 | -0.2 | -0.2 | -0.2 | -0.3 | -0.4 | 0.0 | -1.0 | -1.0 | 0.0 | 0.1 | |
| 2.8 | 5.2 | 10.0 | 17 | 17 | 4.0 | 114 | 10 | -1.0 | 128 | 3.2 | 31 | |
| 0.1 | 0.4 | 2.5 | 7.5 | 2.7 | -12 | 102 | -35 | -51 | 103 | -52 | -36 | |
| -2.8 | -4.8 | -7.5 | -9.1 | -15 | -16 | -12 | -45 | -50 | -26 | -42 | -66 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.